Trial Profile
Effects of a Dopamine Agonist [pramipexole] on Pharmacodynamics of Levodopa in Parkinson's Disease: a Double-Blind Placebo Controlled Crossover Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jan 2010
Price :
$35
*
At a glance
- Drugs Pramipexole (Primary) ; Levodopa
- Indications Parkinson's disease
- Focus Pharmacodynamics
- 01 Jan 2010 Results published in Archives of Neurology.
- 07 May 2008 New trial record.